通过使用Elecsys® HCV Duo Assay加速诊断和开始治疗
Tadashi Namisaki1, Kiyoko Okuno2, Mariko Murai2
1Department of Gastroenterology and Hepatology, Nara Medical University, Kashihara, JPN.
Cureus
|August 4, 2025
概括
同时对型肝炎病毒 (HCV) 抗体和HCV RNA进行测试,有效地确定符合直接作用抗病毒治疗 (DAA) 资格的患者. 这种方法有助于诊断慢性HCV感染并及时开始治疗.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 公共卫生 公共卫生
背景情况:
- 型肝炎病毒 (HCV) 感染是一个重大的全球健康问题.
- 直接作用抗病毒疗法 (DAA) 可以治疗HCV,但需要准确的诊断.
- 确定适合DAA治疗的患者对于有效的HCV消除策略至关重要.
研究的目的:
- 确定具有阳性C型肝炎病毒 (HCV) RNA结果的患者的数量,符合直接作用抗病毒 (DAA) 治疗的条件.
- 确定有效的查方法来检测抗体阳性个体中的HCVRNA.
- 评估在奈良医科大学的抗HCV抗体阳性患者中HCVRNA阳性的流行率.
主要方法:
- 在2021年6月至2024年5月期间对HCV抗体 (Ab) 阳性病例的回顾性评估.
- 分析HCVRNA检测状态,包括RNA检测率和阳性率.
- 胃肠病学部和其他部门之间的RNA阳性率的比较.
主要成果:
- 在866名抗HCV抗体阳性患者中,只有29.2%接受了HCVRNA检测.
- 总体而言,HCV RNA阳性率为16.6% (42/253),而胃肠病学部的比率 (45.6%) 与其他部门 (8.2%) 相比较高.
- 据估计,在未经测试的患者中,另外66名患者可能是HCV RNA阳性,这突显了诊断和DAA资格方面的差距.
结论:
- 同时评估HCV抗体和HCVRNA是一种有效的方法来识别慢性HCV感染的患者.
- 这种综合方法可以显著改善对DAA治疗有资格的患者的识别.
- 优化查方案至关重要,以确保所有符合条件的HCV患者及时接受治疗.
相关概念视频
Enzyme-Linked Immunosorbent Assay
14.1K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
14.1K
Automated Microbial Diagnostics
77
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
77


